Outcomes in Patients Receiving Treatment for Pulmonary Arterial Hypertension Associated With Repaired Congenital Heart Disease

By sjmartinez • February 26, 2025

Krasuski RA, Tobore T, Studer S, Jansa P, Sitbon O, Hoeper MM, Channick R, Gaine S, Lang I, Chin K, Pulido T, Mehta S, Torbicki A, Sastry B, Tang X, McLaughlin V, Reardon LC. Outcomes in Patients Receiving Treatment for Pulmonary Arterial Hypertension Associated With Repaired Congenital Heart Disease. JACC Adv. 2025 Feb 24;4(3):101626. doi: 10.1016/j.jacadv.2025.101626. Epub ahead of print. PMID: 39999520.

Tags: Cardiology/Epi, COMPASS-2, congenital heart disease, GRIPHON, Pooled analysis, Publications, pulmonary arterial hypertension, Pulmonary, Critical Care & Sleep Medicine, SERAPHIN

Insurance-Based Disparities in Cardiac Allograft Vasculopathy After Heart Transplantation Are Mediated by Care at High-Volume Centers

Sakowitz S, Bakhtiyar SS, Mallick S, Pereira S, Nelson JS, Parikh R, Higgins RSD, Shemin RJ, Benharash P. Insurance-Based Disparities in Cardiac Allograft Vasculopathy After[...]

Engineering noncovalent π-stacked organic framework for intrinsic near-infrared photoactivated drug delivery

Fu R, Meng D, Han X, Liu L, Chen C, Zheng R, Zhao Y, Zhang X, Lin X, Hasani M, Song Y, Liang T, Wen[...]

Early U.S. Commercial Experience With a Novel Transcatheter Edge-to-Edge Repair System: Insights From Real-World Data

Waggoner T, Garcia S, Chakravarty T, Makar M, Latib A, Kipperman RM, Zahr F, Hanson I, Sinha AK, Sharma RP, Depta JP, Castellanos JA, Kodali[...]